Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Upskill | 2020 | Secondary Market | Undisclosed | Vienna |
| Fetchr | 2020 | Series C | $15.0M | Dubai |
| Aurinia Pharmaceuticals | 2020 | Post Ipo Equity | $200.0M | Victoria |
| CoEdition | 2020 | Series Unknown | $8.0M | New York |
| Pionyr Immunotherapeutics | 2020 | Corporate Round | $275.0M | South San Francisco |
| Surface Oncology | 2020 | Post Ipo Equity | $28.9M | Cambridge |
| Oyster Point Pharmaceuticals | 2020 | Post Ipo Equity | $120.8M | San Francisco |
| Akouos | 2020 | Series B | $105.0M | Boston |
| Millendo Therapeutics | 2020 | Post Ipo Equity | $50.0M | Ann Arbor |
| Noonlight | 2020 | Corporate Round | Undisclosed | St Louis |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 351 | Upskill | Secondary Market | Undisclosed | Vienna, United States |
| 352 | Fetchr | Series C | $15.0M | Dubai, United Arab Emirates |
| 353 | Aurinia Pharmaceuticals | Post Ipo Equity | $200.0M | Victoria, Canada |
| 354 | CoEdition | Series Unknown | $8.0M | New York, United States |
| 355 | Pionyr Immunotherapeutics | Corporate Round | $275.0M | South San Francisco, United States |
| 356 | Surface Oncology | Post Ipo Equity | $28.9M | Cambridge, United States |
| 357 | Oyster Point Pharmaceuticals | Post Ipo Equity | $120.8M | San Francisco, United States |
| 358 | Akouos | Series B | $105.0M | Boston, United States |
| 359 | Millendo Therapeutics | Post Ipo Equity | $50.0M | Ann Arbor, United States |
| 360 | Noonlight | Corporate Round | Undisclosed | St Louis, United States |
Upskill provides wearable technology to connect hands-on workers from the factory to the warehouse to the jobsite.
Fetchr is an international express, mail delivery and logistics services company.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
CoEdition is a retail company that specializes in the fashion marketplace dedicated to women.
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Akouos is a biotechnology company focusing on restoring and preserving hearing.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
Noonlight combines advanced technology (APIs) with real humans to protect and comfort people so they can live freely.
Flow is a platform that enables e-commerce companies to go global.
Frontier Car Group develops, launches, and operates used-automotive marketplaces within emerging market economies.
The Yes is a next generation AI-powered shopping platform.
Jyve is a tech platform that matches brands’ in-store execution needs with the right skilled labor, at the right time.
Stockwell is combining the convenience of online ordering with the instant gratification of real world retail.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
Drive.ai creates AI software for autonomous vehicles.
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Holloway publishes comprehensive practical Guides, each researched, written, and refined by experts.
Enigma provides reliable data and insights on the identity, activity, and risk profile of every small business.
Uptake Technologies designs and develops enterprise software.
Igneous offers an unstructured data management solution giving data-centric enterprises visibility, protection, and data mobility at scale.
Influitive is a software development company that provides content creation, training, product adoption, and employee advocacy services.
Catalytic offers the easiest platform for digital transformation and the automation of knowledge work.
Customer Journey Intelligence
New Enterprise Associates has invested in 461 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Biotechnology, Internet, Software, Health Care, E-Commerce. The firm invests across 64 different industry categories.
Among tracked funding rounds, Frontier Car Group received $400.0M in a Series D round. New Enterprise Associates's total known invested capital is $21.4B.
New Enterprise Associates's average investment size is $66.5M across its portfolio of 461 companies.
Recent New Enterprise Associates portfolio additions include Upskill, Fetchr, Aurinia Pharmaceuticals, CoEdition, Pionyr Immunotherapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors